Financhill
Back

Eton Pharmaceuticals Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
61

ETON
Eton Pharmaceuticals

Last Price:
8.63
Seasonality Move:
9.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Eton Pharmaceuticals Price Quote

$8.63
-0.04 (-0.46%)
(Updated: November 7, 2024 at 2:20 PM ET)

Eton Pharmaceuticals Key Stats

Buy
61
Eton Pharmaceuticals (ETON) is a Buy

Day range:
$8.62 - $8.85
52-week range:
$3.03 - $9.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.91
P/B ratio:
16.16%

Volume:
107K
Avg. volume:
183.9K
1-year change:
96.6%
Market cap:
$217.5M
Revenue:
$31.6M
EPS:
$-0.26

How Much Does Eton Pharmaceuticals Make?

Is Eton Pharmaceuticals Growing As A Company?

  • What Is Eton Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.24%
  • What Is Eton Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Eton Pharmaceuticals Stock Price Performance

What Is Eton Pharmaceuticals 52-Week High & Low?

Eton Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Eton Pharmaceuticals?

Is Eton Pharmaceuticals Cash Flow Positive?

  • What Is ETON Cash Flow From Operations?
    Cash flow from operations (TTM) is $42K
  • What Is Eton Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3M
  • What Is Eton Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.7M

Eton Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ETON return on invested capital is -31.86%
  • What Is Eton Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -21.32%
  • What Is ETON Return On Equity?
    ROE is a measure of profitability and is -42.84%

Eton Pharmaceuticals Earnings Date & Stock Price

Eton Pharmaceuticals Competitors

Eton Pharmaceuticals Dividend Yield

Eton Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -71.43%
Revenue: -24.36% 3.11%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.00
Upside from Last Price: 49.94%

Major Shareholders

  • How many ETON shares are owned by institutional investors?
    11.2M ETON shares are owned by institutional investors
  • How many ETON shares are owned by insiders?
    2M ETON shares are owned by insiders